Skeletal Radiology

, Volume 40, Issue 12, pp 1505–1513 | Cite as

Radiological aspects of Gaucher disease

  • Robert KatzEmail author
  • Tom Booth
  • Rikin Hargunani
  • Peter Wylie
  • Brian Holloway
Review Article


Advances in imaging and the development of commercially available enzyme therapy have significantly altered the traditional radiology of Gaucher disease. The cost of treatment and need for monitoring response to therapy have magnified the importance of imaging. There are no recent comprehensive reviews of the radiology of this relatively common lysosomal storage disease. This article describes the modern imaging, techniques and radiological manifestations of Gaucher disease.


Gaucher Lysosomal BMB ERT Imaging 



The authors would like to thank Dr Atul Mehta and Dr Derralynn Hughes of the Lysosomal Storage Disease Unit, Royal Free Hospital and Dr Mario Maas, Academic Medical Centre, University of Amsterdam for their valuable input in the preparation of this manuscript.


  1. 1.
    Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249–54.CrossRefGoogle Scholar
  2. 2.
    Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. ii. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem Biophys Res Commun. 1965;18:221–5.CrossRefGoogle Scholar
  3. 3.
    Brady RO. Gaucher’s disease: past, present and future. Baillières Clin Haematol. 1997;10:621–34.CrossRefGoogle Scholar
  4. 4.
    Cox TM, Schofield JP. Gaucher’s disease: clinical features and natural history. Baillières Clin Haematol. 1997;10(4):657–89.CrossRefGoogle Scholar
  5. 5.
    Charrow J, Andersson HC, Kaplan P, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160(18):2835–43.CrossRefGoogle Scholar
  6. 6.
    Vom Dahl S, Poll L, Di Rocco M, et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin. 2006;22(6):1045–64.CrossRefGoogle Scholar
  7. 7.
    Charrow J. Enzyme replacement therapy for Gaucher disease. Expert Opin Biol Ther. 2009;9(1):121–31. Review.CrossRefGoogle Scholar
  8. 8.
    Ficicioglu C. Review of miglustat for clinical management in Gaucher disease type 1. Ther Clin Risk Manage. 2008;4(2):425–31.CrossRefGoogle Scholar
  9. 9.
    Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. 2008;372(9645):1263–71.CrossRefGoogle Scholar
  10. 10.
    Weinreb NJ, Aggio MC, Andersson HC, et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol. 2004;41(4 Suppl 5):15–22.CrossRefGoogle Scholar
  11. 11.
    Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B. Skeletal aspects of Gaucher disease: a review. Br J Radiol. 2002;75 Suppl 1:A2–A12.CrossRefGoogle Scholar
  12. 12.
    Pastores GM, Patel MJ, Firooznia H. Bone and joint complications related to Gaucher disease. Curr Rheumatol Rep. 2000;2(2):175–80.CrossRefGoogle Scholar
  13. 13.
    Maas M, Poll LW, Terk MR. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol. 2002;75 Suppl 1:A13–24.CrossRefGoogle Scholar
  14. 14.
    Sims KB, Pastores GM, Weinreb NJ, et al. Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study. Clin Genet. 2008;73(5):430–40. Epub 2008 Feb 27.CrossRefGoogle Scholar
  15. 15.
    Hermann G, Shapiro RS, Abdelwahab IF, Grabowski G. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol. 1993;22(4):247–51.CrossRefGoogle Scholar
  16. 16.
    Maas M, van Kuijk C, Stoker J, et al. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience. Radiology. 2003;229(2):554–61. Epub 2003 Oct 2.CrossRefGoogle Scholar
  17. 17.
    Yosipovitch Z, Katz K. Bone crisis in Gaucher disease–an update. Isr J Med Sci. 1990;26(10):593–5.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Charrow J, Dulisse B, Grabowski GA, Weinreb NJ. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease. Clin Genet. 2007;71(3):205–11.CrossRefGoogle Scholar
  19. 19.
    Poll LW, Maas M, Terk MR, et al. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol. 2002;75 Suppl 1:A25–36.CrossRefGoogle Scholar
  20. 20.
    Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002;113(2):112–9.CrossRefGoogle Scholar
  21. 21.
    Johnson LA, Hoppel BE, Gerard EL, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology. 1992;182(2):451–5.CrossRefGoogle Scholar
  22. 22.
    Maas M, Hollak CE, Akkerman EM, Aerts JM, Stoker J, Den Heeten GJ. Quantification of skeletal involvement in adults with type I Gaucher’s disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol. 2002;179(4):961–5.CrossRefGoogle Scholar
  23. 23.
    Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 1995;96(4 Pt 1):629–37.Google Scholar
  24. 24.
    Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol Dis. 2001;27(6):1005–12.CrossRefGoogle Scholar
  25. 25.
    Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am. 1986;68(6):802–8.CrossRefGoogle Scholar
  26. 26.
    Poll LW, Koch JA, vom Dahl S, et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol. 2001;30(9):496–503.CrossRefGoogle Scholar
  27. 27.
    Terk MR, Dardashti S, Liebman HA. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol. 2000;29(10):563–71.CrossRefGoogle Scholar
  28. 28.
    Vlieger EJ, Maas M, Akkerman EM, Hollak CE, Den Heeten GJ. Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease. J Comput Assist Tomogr. 2002;26(5):843–8.CrossRefGoogle Scholar
  29. 29.
    Robertson PL, Maas M, Goldblatt J. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher’s disease using the bone marrow burden score. AJR Am J Roentgenol. 2007;188(6):1521–8.CrossRefGoogle Scholar
  30. 30.
    DeMayo RF, Haims AH, McRae MC, Yang R, Mistry PK. Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher’s Disease. AJR Am J Roentgenol. 2008;191(1):115–23.CrossRefGoogle Scholar
  31. 31.
    McHugh K, Olsen EØE, Vellodi A. Gaucher disease in children: radiology of non-central nervous system manifestations. Clin Radiol. 2004;59(2):117–23.CrossRefGoogle Scholar
  32. 32.
    Pastores GM, Wallenstein S, Desnick RJ, Luckey MM. Bone density in type 1 Gaucher disease. J Bone Miner Res. 1996;11(11):1801–7.CrossRefGoogle Scholar
  33. 33.
    Mikosch P, Kohlfürst S, Gallowitsch HJ, et al. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature. Nuklearmedizin. 2008;47(6):239–47. Review.CrossRefGoogle Scholar
  34. 34.
    Hermann G, Goldblatt J, Levy RN, Goldsmith SJ, Desnick RJ, Grabowski GA. Gaucher’s disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am J Roentgenol. 1986;147(5):943–8.CrossRefGoogle Scholar
  35. 35.
    Mariani G, Filocamo M, Giona F, et al. Severity of bone marrow involvement in patients with Gaucher’s disease evaluated by scintigraphy with 99mTc-sestamibi. J Nucl Med. 2003;44(8):1253–62.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Mariani G, Molea N, La Civita L, Porciello G, Lazzeri E, Ferri C. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher’s disease. Eur J Nucl Med. 1996;23(4):466–70.CrossRefGoogle Scholar
  37. 37.
    Katz K, Mechlis-Frish S, Cohen IJ, Horev G, Zaizov R, Lubin E. Bone scans in the diagnosis of bone crisis in patients who have Gaucher disease. J Bone Joint Surg Am. 1991;73(4):513–7.CrossRefGoogle Scholar
  38. 38.
    Charrow J, Andersson HC, Kaplan P, et al. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations. J Pediatr. 2004;144(1):112–20.CrossRefGoogle Scholar
  39. 39.
    Hill SC, Damaska BM, Ling A, et al. Gaucher disease: abdominal MR imaging findings in 46 patients. Radiology. 1992;184(2):561–6.CrossRefGoogle Scholar
  40. 40.
    Poll LW, Koch JA, vom Dahl S, Sarbia M, Häussinger D, Mödder U. Gaucher disease of the spleen: CT and MR findings. Abdom Imaging. 2000;25(3):286–9.CrossRefGoogle Scholar
  41. 41.
    Terk MR, Esplin J, Lee K, Magre G, Colletti PM. MR imaging of patients with type 1 Gaucher’s disease: relationship between bone and visceral changes. AJR Am J Roentgenol. 1995;165(3):599–604.CrossRefGoogle Scholar
  42. 42.
    Patlas M, Hadas-Halpern I, Abrahamov A, Elstein D, Zimran A. Spectrum of abdominal sonographic findings in 103 pediatric patients with Gaucher disease. Eur Radiol. 2002;12(2):397–400. Epub 2001 Sep 7.CrossRefGoogle Scholar
  43. 43.
    Tunaci A, Berkmen YM, Gökmen E. Pulmonary Gaucher’s disease: high-resolution computed tomographic features. Pediatr Radiol. 1995;25(3):237–8.CrossRefGoogle Scholar
  44. 44.
    Wolson AH. Pulmonary findings in Gaucher’s disease. Am J Roentgenol Radium Ther Nucl Med. 1975;123(4):712–5.CrossRefGoogle Scholar
  45. 45.
    Amir G, Ron N. Pulmonary pathology in Gaucher’s disease. Hum Pathol. 1999;30(6):666–70.CrossRefGoogle Scholar
  46. 46.
    de Fost M, Aerts JM, Hollak CE. Gaucher disease: from fundamental research to effective therapeutic interventions. Neth J Med. 2003;61(1):3–8.Google Scholar

Copyright information

© ISS 2010

Authors and Affiliations

  • Robert Katz
    • 1
    Email author
  • Tom Booth
    • 1
  • Rikin Hargunani
    • 1
  • Peter Wylie
    • 1
  • Brian Holloway
    • 1
  1. 1.Radiology DepartmentRoyal Free HospitalLondonUK

Personalised recommendations